Smith & Nephew (SNN) agrees to acquire Healthpoint Biotherapeutics for $782M, allowing the...

|About: Smith & Nephew plc (SNN)|By:, SA News Editor

Smith & Nephew (SNN) agrees to acquire Healthpoint Biotherapeutics for $782M, allowing the British medical products manufacturer to expand into the wound therapy sector. SNN expects the acquisition to exceed its cost of capital in the third full year following acquisition, to be broadly EPSA neutral in 2013 and accretive thereafter.